Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grace Dolman

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Australian & New Zealand Journal of Obstetrics & Gynaecology|January 13, 2006
Should the Pap smear be repeated at the first colposcopy visit?Grace Dolman, Jeffrey Tan, Michael Quinn
Journal of Viral Hepatitis|June 2, 2022
Hepatitis E case series: A UK experienceAnne Robins, Grace Dolman, Simon Williams, et al.
Magma (New York, N.Y.)|December 20, 2022
Comparing magnetic resonance liver fat fraction measurements with histology in fibrosis: the difference between proton density fat fraction and tissue mass fat fractionStephen James Bawden, Caroline Hoad, Philip Kaye, et al.
EMBO Molecular Medicine|November 8, 2017
SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosisVarinder S Athwal, James Pritchett, Jessica Llewellyn, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Australian & New Zealand Journal of Obstetrics & Gynaecology|January 13, 2006
Should the Pap smear be repeated at the first colposcopy visit?Grace Dolman, Jeffrey Tan, Michael Quinn
Journal of Viral Hepatitis|June 2, 2022
Hepatitis E case series: A UK experienceAnne Robins, Grace Dolman, Simon Williams, et al.
Magma (New York, N.Y.)|December 20, 2022
Comparing magnetic resonance liver fat fraction measurements with histology in fibrosis: the difference between proton density fat fraction and tissue mass fat fractionStephen James Bawden, Caroline Hoad, Philip Kaye, et al.
EMBO Molecular Medicine|November 8, 2017
SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosisVarinder S Athwal, James Pritchett, Jessica Llewellyn, et al.
Pageof 1